Delta Opioid Receptors Selectively Inhibit Nerve-Driven Contractions in Human Colon

Delta opioid agonists selectively blocked nerve-stimulated colon contractions without affecting spontaneous muscle activity — showing nerve-specific opioid control of human gut.

Chamouard, P et al.·European journal of pharmacology·1994·Preliminary Evidencein-vitro
RPEP-00286In VitroPreliminary Evidence1994RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Delta opioid receptor agonists selectively inhibited nerve-stimulated contractions in human colon tissue without affecting spontaneous contractile activity.

Key Numbers

How They Did This

Researchers used superfused strips of human sigmoid colon (both longitudinal and circular muscle). They applied delta opioid agonists and measured spontaneous activity and responses to electrical nerve stimulation.

Why This Research Matters

Understanding how opioid receptors control colon nerve signaling helps explain opioid-related constipation and could lead to better treatments for gut motility disorders.

The Bigger Picture

Understanding how different opioid receptor types affect human colon function is essential for managing opioid-induced constipation and developing gut-specific treatments.

What This Study Doesn't Tell Us

In vitro study using human tissue samples. The isolated tissue setting does not fully replicate how the colon functions inside the body with its full nerve supply and hormonal environment.

Questions This Raises

  • ?Could delta-selective drugs be used to treat specific gut motility disorders?
  • ?Do mu and kappa receptors have similar or different selectivity for nerve vs muscle activity?

Trust & Context

Key Stat:
Nerve-selective inhibition Delta agonists blocked nerve-stimulated contractions but not spontaneous muscle contractions — a precisely targeted effect
Evidence Grade:
Preliminary — in vitro human tissue study. Uses actual human colon tissue (strong) but in an isolated setting (limited).
Study Age:
Published in 1994 (32 years ago). Human tissue data remains valuable for translational relevance.
Original Title:
Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon.
Published In:
European journal of pharmacology, 262(1-2), 33-9 (1994)
Database ID:
RPEP-00286

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why only nerve-driven contractions?

Delta opioid receptors appear to be located on nerve endings in the colon rather than on muscle cells. So they only affect contractions that depend on nerve signaling, not the muscle's own rhythmic activity.

How does this relate to constipation from opioids?

By selectively inhibiting nerve-driven contractions, opioids reduce the coordinated propulsive movements that move stool through the colon, while basic muscle tone continues.

Read More on RethinkPeptides

Cite This Study

RPEP-00286·https://rethinkpeptides.com/research/RPEP-00286

APA

Chamouard, P; Rohr, S; Meyer, C; Baumann, R; Angel, F. (1994). Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon.. European journal of pharmacology, 262(1-2), 33-9.

MLA

Chamouard, P, et al. "Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon.." European journal of pharmacology, 1994.

RethinkPeptides

RethinkPeptides Research Database. "Delta-opioid receptor agonists inhibit neuromuscular transmi..." RPEP-00286. Retrieved from https://rethinkpeptides.com/research/chamouard-1994-deltaopioid-receptor-agonists-inhibit

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.